Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00721877 · ClinicalTrials.gov registry record · Phase 1
Resveratrol in Healthy Adult Participants
A Phase 1 study, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- Phase 1
- Development phase
- 42
- Enrollment target
NCT00721877: Completed Phase 1 study, sponsored by National Cancer Institute (NCI).
NCT00721877 is a Phase 1 study that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 42 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00721877, a Phase 1 study, has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 42 participants
- Enrollment target
Study Summary
Resveratrol may prevent cancer in healthy people. Studying samples of blood and urine in the laboratory from participants who are taking resveratrol may help doctors learn more about how this drug is used by the body. This phase I trial is studying the side effects of resveratrol and to see how it works in healthy adult participants.
Interventions
- OTHER laboratory biomarker analysis
- OTHER pharmacological study
- DRUG resveratrol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2008-08 |
| Est. Completion | 2009-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00721877
The ClinicalTrials.gov registry entry for NCT00721877 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which laboratory biomarker analysis is the first listed.
NCT00721877 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00721877 about?
NCT00721877 is a clinical study titled "Resveratrol in Healthy Adult Participants". Resveratrol may prevent cancer in healthy people. Studying samples of blood and urine in the laboratory from participants who are taking resveratrol may help doctors learn more about how this drug is used by the body. This phase I trial is studying the side effects of resveratrol and to see how it w...
What is the current status of trial NCT00721877?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 42 participants. The study started on 2008-08. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00721877?
The interventions under investigation include: laboratory biomarker analysis (OTHER), pharmacological study (OTHER), resveratrol (DRUG).
Who is sponsoring clinical trial NCT00721877?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.